Ren J; Bird LE; Chamberlain PP; in sod. (2002). »Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors«. Proc Natl Acad Sci USA. 99: 14410–15. doi:10.1073/pnas.222366699. PMID12386343.
nih.gov
ncbi.nlm.nih.gov
Cespedes MS, Aberg JA. Neuropsychiatric complications of antiretroviral therapy. Drug Safety. 2006;29(10):865-74. PMID 16970510
Hasse B, Günthard HF, Bleiber G, Krause M. Efavirenz intoxication due to slow hepatic metabolism. Clinical Infectious Diseases. 2005 Feb 1;40(3):e22-3. PMID 15668854
Lowenhaupt EA, Matson K, Qureishi B, Saitoh A, Pugatch D. Psychosis in a 12-year-old HIV-positive girl with an increased serum concentration of efavirenz. Clinical Infectious Diseases. 2007 Nov 15;45(10):e128-30. PMID 17968817
Rossi S, Yaksh T, Bentley H, van den Brande G, Grant I, Ellis R. Characterization of interference with 6 commercial delta9-tetrahydrocannabinol immunoassays by efavirenz (glucuronide) in urine. Clinical Chemistry. 2006 May;52(5):896-7. PMID 16638958
Röder CS, Heinrich T, Gehrig AK, Mikus G. Misleading results of screening for illicit drugs during efavirenz treatment. AIDS. 2007 Jun 19;21(10):1390-1. PMID 17545727
pubmed.ncbi.nlm.nih.gov
Ren J; Bird LE; Chamberlain PP; in sod. (2002). »Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors«. Proc Natl Acad Sci USA. 99: 14410–15. doi:10.1073/pnas.222366699. PMID12386343.
aidsinfo.nih.gov
DHHS panel. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (10. oktober 2006). (dostopno na AIDSInfoArhivirano 2006-05-06 na Wayback Machine.)
web.archive.org
DHHS panel. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (10. oktober 2006). (dostopno na AIDSInfoArhivirano 2006-05-06 na Wayback Machine.)
